Emphatic About
the Glymphatic
SCIENTIFIC KENYON

The Brain’s Waste Removal System as
Therapy for Alzheimer’s Disease
By Katrina Simchick

Illustration of a lymph gland
By E. A. Schaffer, Text-book of microscopic anatomy.
from Wellcome Collection (CC BY 4.0)

63

A

s modern medicine
and science continues
to advance, we are
able to live longer thanks to better
cures and treatments as well as
better knowledge on how to stay
healthy. This seems positive, right?
However, our ability to live longer
increases the aging population and
therefore increases the presence of
aging related problems. By 2030,
just 10 years away, US individuals
65 and older are expected to
outnumber those 18 and under10.
This increased aging population will
require more geriatric caregivers
and funding than ever before.
Additionally, as people live longer,
there will be a surge in the number
of people with age-related diseases
and afflictions, such as Alzheimer’s
disease.
Alzheimer’s disease is the
6th leading cause of death in
the United States and there is
currently no cure. Alzheimer’s
patients originally suffer from
mostly cognitive deficits, including
language
comprehension,
problem-solving, and most notably,
memory. There are countless
representations in popular media
depicting the Alzheimer’s patient
unable to remember their friends
and family. And while this is a very
real and devastating effect of the
disease, Alzheimer’s does not stop
there. As the disease worsens and
spreads, other basic functions,
such as movement, breathing,
and speaking, are also affected
and patients need round-the-clock
care. Right now, around 6 million
Americans are living with the
disease, but due to the growing
elderly population, this number is
expected to more than double by
20501. To help solve and assuage
this current problem afflicting our
society, there is an entire field of
scientific research dedicated to
uncovering how the disease works
and exploring different therapies
and possible treatments.
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A current treatment approach
involves the mechanisms employed
in cellular waste removal - basically
how our brains take out the trash. The
glymphatic system, a term coined
by Iliff and colleagues, refers to this
proposed waste removal system of
our brains. This system increases
the brain’s clearance of Alzheimer’s
causing proteins while we sleep.
Could we then use sleep, an innate
human function, as a method for
getting rid of these degenerative
proteins? Researchers are now
looking to further understand how
the glymphatic system works so
that it can potentially be harnessed
as a treatment for eradicating
those degenerative proteins in
Alzheimer’s patients5. This begs the
question: how exactly can sleep be
an Alzheimer’s cure?

How Our Brains Take
Out the Trash
Let’s set the scene: Our brains
are made up of billions of neurons
that connect to each other, helping
us to eat, sleep, breathe, and do
everything else that we do. Just
like the rest of the body, our brain
also requires oxygen to function.
This is achieved through veins and
arteries that penetrate the brain. A
barrier is made between the brain’s
vasculature and the interstitial fluid
(ISF), the fluid that sits between
cells and capillaries. The barrier is
made up of cells that are packed
tightly together so only things that
are really small can pass through.
The selected solutes and molecules
then seep past surrounding glial
cells, another type of cell found in
the brain, and into the ISF. Our brain
is also surrounded by cerebrospinal
fluid (CSF), a bodily fluid that’s
used to keep the brain buoyant, to
protect the brain, and to maintain
levels of substances that our brain
needs and secretes.
The glymphatic system arose
from research trying to uncover

how our brain got rid of its waste.
In the body, the lymphatic system
gets rid of cellular waste and
maintains the balance of fluids,
which prevents fluid build up by
draining the interstitial fluid into
lymphatic vessels34. Neurons, just
like all other cells in our body, create
waste due to the large amount of
molecules and substances they are
making and secreting in order to
function properly. This is secreted
into the ISF. However, the brain
does not have any lymphatic
vessels that could be used to move
fluid and maintain this balance in
the brain. The brain must have a
way of getting rid of this waste to
avoid build up, which could lead
to problems with neuron function.
So even though scientists know
that the brain has fluid movement
similar to the lymphatic system,
they were unsure of how it was
being done without any lymphatic
vessels 7, 16.
While the glymphatic pathway
and CSF waste removal has been a
recent interest, the study of CSF
flow into and out of the brain has
been around for a long time. In
the 1970’s Cserr and colleagues
discovered that when they injected
solutes into CSF filled spaces,
they were transported faster than
expected. This told them that
something in the brain was helping
this fluid move and circulate, that it
was not moving of its own accord7.
This sparked quite a few studies that
looked at the perivascular transport
of CSF, that is the transport of CSF
into the brain along arteries and
veins. It was discovered that when
a substance was injected into the
CSF, the substance entered the
brain along the arteries at a very
rapid speed due to the arterial
pulsations 7, 29.
In 2012, Iliff and colleagues
repeated these past experiments
but with advanced technology to
see what they would find. They
too saw that CSF was entering the
64
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Figure 1. The Glymphatic Pathway: 1) CSF enters the brain through the periarterial space. 2) It then leaves the periarterial space with the help of the
AQP4, entering the interstitial space which is filled with ISF and waste. 3) This causes the CSF and ISF to go through an exchange, 4) the CSF pushing
the ISF out of the interstitial space and into the perivenous space, 5) through which it exits the brain15,28.
Original image by Katrina Simchick

brain along the arteries very rapidly.
However, they also demonstrated
that molecules in the interstitial
space (the space between cells
where ISF resides) were cleared
from the brain along the veins.
This created a model for how the
glymphatic pathway, a term they
coined, worked15. As demonstrated
in Figure 1, the CSF enters the
brain through the periarterial
space, which is the space between
the around and the protective
sheath. It then diffuses into the
interstitial space which drives the
ISF and accumulated cellular waste
towards the veins, where it exits
the brain along the perivenous
space, the space between veins
and the protective sheath 7, 8, 14,
15
. In a way, you can think of the
glymphatic system like the ocean.
Shells and pebbles litter the beach
until suddenly a wave washes
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ashore and then all those pebbles
and shells are gone. The CSF, like
a wave, comes in and washes the
waste and ISF back out along the
veins.

The Driver’s Seat:
What Drives the
Glymphatic System?
They next wanted to answer
the questions of scientists before
them: Why was the CSF and ISF
able to move through this pathway
so quickly? Iliff and colleagues
decided to look at the function of
AQP4. AQP4 are water channels,
so it would make sense that they
are involved in fluid distribution,
as a large component of CSF and
ISF is water. These channels hang
out around the glial sheath that
encases the blood vessels 8, 15. To

get a better picture of this, imagine
the blood vessel is a hot dog, the
glia are the bun, and the AQP4
are sesame seeds. The glia act as
a barrier between the perivascular
spaces and the interstitial space.
The job of AQP4 is to pump
fluids from within the perivascular
space across the glia and into the
interstitial space. When the AQP4
is removed from the brain, the flow
of CSF is reduced. The CSF still
enters the brain along the arteries,
but it no longer moves into the
interstitial space, which decreases
waste removal by about 70%15.
In addition to the AQP4 water
channels, there is also a physical
force that helps to move the fluids
and cellular waste. However, there
is controversial and conflicting
evidence as to what is responsible.
One possibility is the pressuredriven bulk flow model. This model
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suggests that the pulsation of our
arteries as our blood circulates
drives the CSF into the brain. This
arterial pulsation creates a “bulk
flow” or the movement of all the
liquid at once, everything moving
together at the same time 2, 12, 13,
23
. A good example of bulk flow
is a river: the water all flows down
the river together. This model also
proposes that because of a higher
fluid pressure in the periarterial
space, it pushes the CSF into the
interstitial space where it then flows
towards a low pressure area, the
perivenous space 7, 13. If we think
about rivers, the incoming pushes
the water further downstream,
where there is less, so that it doesn’t
overflow.
However,
some
research
suggests that this bulk flow
hypothesis doesn’t make sense.
Instead, they suggest that cellular
waste exits the brain because of
diffusion 3, 4, 13. This basically means
that when there is a build up of
cellular waste, it drifts to where
there is no or less waste in order
to create a balance. Diffusion is
also based on molecule size: the
smaller the molecule, the faster
the diffusion. Therefore, smaller
molecules will be able to move
faster than large molecules in the
same amount of time. In bulk flow,
the size of the molecule doesn’t
matter as everything is being
pushed together in one direction.
In diffusion models, once the CSF
enters the interstitial space, the
small molecules move faster than
the large molecules when measured
at 60 minutes 34. Current research is
trying to untangle this vast range
of evidence to find out which one,
either bulk flow or diffusion, is the
driver.

The Glymphatic Exit
As the field has continued to
expand, debate has also sparked
over how exactly the glymphatic
system gets rid of the waste. Iliff

and colleagues’ original findings
suggest that the flow of CSF pushes
the ISF and waste out of the brain
through the perivenous space15.
While most evidence agrees that
CSF enters the brain through
arterial space and mixes with the
ISF in the interstitial space, there is
conflicting evidence about how it
exits the brain (Fig. 2).
One alternative mechanism is
that instead of exiting via the veins,
it can exit via the arteries, meaning
it exits the brain the same way it
entered. Evidence supporting this
model complicates the glymphatic
concept as it shows a completely
opposite exit as it goes against
the grain of the inflow 6, 8, 13 . The
difference in evidence supporting
these two exit models could be
due to differences in experimental
technique. More research is
currently being done to figure out
whether the convective flow of
the glymphatic pathway results
in drainage along veins or along
arteries 7, 8.
Another possible exit strategy
for ISF and cellular waste is along
cranial nerves. These are the nerves
that exit our brains, but don’t go
very far as they control the motions

of our head and neck, including
tongue, eye, and nose movements.
As previously suggested, the CSF
flows into the interstitial space
through the arterial space, but
instead of exiting along any blood
vessels, it exits through the cranial
nerve 7, 8, 13. While there is strong
evidence to support this model,
it is unknown whether or not it
works in conjunction with the other
exit pathways or if it is the major
clearance route. As the field moves
forward, these different models
will be tested to determine how all
these different pieces of evidence
fit together.

So What’s the
Connection Between
the Glymphatic
System and
Alzheimer’s?
The neurons in our brain
make a protein called amyloidbeta. Neurons secrete this protein
into the interstitial space once it is
no longer needed, so it becomes
another cellular waste product.

Figure 2. The Glymphatic Exit: How does the cellular waste actually leave the brain? 1) The
glymphatic model proposes the ISF and cellular waste exits the brain along the veins. 2) Another
model suggests that the waste exits the brain along the arteries, leaving through the same route
it entered. 3) A third model proposes that the ISF and waste leaves along the cranial nerves. It is
debated whether or not it works by itself or in conjunction with the other proposed methods.
Original image by Katrina Simchick
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After it is dumped, it is cleared out of
the brain by the glymphatic system.
However, Alzheimer’s disrupts this
process. In an Alzheimer’s brain,
this protein is made incorrectly
so that they bind together and
form plaques, or clumps of the
protein. These plaques stick
to neurons and accumulate,
smothering the neurons until they
are no longer able to receive the
proper nutrients causing them to
die. It is this neuronal death, the
neurodegeneration, which causes
cognitive deficits as the neurons can
no longer communicate or function
properly20. So while a normally
functioning brain gets rid of
amyloid-beta, the Alzheimer’s brain
has a build up of these proteins
which cause neurodegeneration.
This accumulation of this “bad”
protein is likely due to the
malfunctioning glymphatic system
in Alzheimer’s disease.
Research shows that glymphatic
function is weakened in Alzheimer’s
disease27. The AQP4 channels,
which help move CSF into the brain
through to the interstitial space, are
decreased along the arteries. This
in turn causes a decrease in the
ability of CSF to exchange with the
ISF, resulting in less efficient waste
clearance which leads to build-up
of waste 11, 23, 36. Specifically, the
amyloid-beta protein will remain in
the brain for longer which increases
the likelihood of them forming
plaques and sticking to neurons.
As more and more amyloid-beta
plaques accumulate, they affect the
AQP4 further, worsening the brain’s
ability to clear amyloid-beta 38.
So researchers put two and
two together: If in a normally
functioning brain, amyloid-beta
is cleared by the glymphatic
system, and if Alzheimer’s is a
result of accumulated amyloidbeta that is in part due to a lack of
waste clearance, then promoting
glymphatic function in Alzheimer’s
brain may lead to less plaque
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build up. This could then decrease
neurodegeneration and therefore
improve cognition. The question is
- how can glymphatic function be
improved? One word: Sleep!

The Night Shift:
How the Glymphatic
System Works at
Night
The amount of amyloid-beta
present in our brains is regulated
by the sleep-wake cycle. The
protein is present at higher levels
when we are awake and lower
levels when we are asleep. This
fluctuation is caused by changes
in neuronal activity 17, 22, 31. During
the day, when we are awake, there
is a lot of activity in our brain due
to neurons constantly and rapidly
firing in order to carry out our daily
functions. This neuronal activity is
what encourages the production
of proteins like amyloid-beta.
When we go to sleep, this neuronal
activity is diminished and our brains
enter a restful period, leading to a
decrease in protein production5.
Basically,
increased
neuronal
activity while we are awake makes
the amyloid beta, leading to
the higher levels, while at night,
protein production is halted. But
what is actually lowering the levels
at night? It’s the glymphatic system!
In sleeping mice, CSF enters
the brain along the arteries and
moves into the brain tissue, which
follows the glymphatic model.
However, CSF influx is 95% less
in awake mice in comparison to
sleeping mice, illustrating that very
little CSF enters the brain while
we are awake35. Sleep regulates
the glymphatic pathway because
the sleeping brain allows for the
necessary flow of CSF into the
brain tissue while the awake brain
suppresses this influx. Additionally,
amyloid-beta clears twice as fast
in sleeping mice than in mice

who are awake 8, 15. This evidence
is consistent with the glymphatic
theory. When the brain is asleep,
the CSF enters the brain along the
arteries and enters the interstitial
space where it pushes the amyloidbeta to leave the brain. As the
brain awakens, CSF slows its influx
into the brain, leading to less
clearance during the day and an
accumulation of amyloid-beta as
it continues to be produced. The
glymphatic pathway accounts for
the difference between the amount
of amyloid-beta when you’re awake
versus when you’re asleep due to
these changes in clearance.
This influx of CSF while
sleeping is likely due to an increase
in the size of the interstitial space
of sleeping mice compared to
awake mice. One study showed
that in mice, the interstitial space
can increase more than 60% when
sleeping when compared to the
awake brain15. As the brain’s activity
slows during sleep, this area
between the neurons expands,
creating more space for CSF to fill as
it flows in. Conversely, as the brain
awakens and activity increases,
this space shrinks, preventing CSF
in flow because there is no longer
enough space for the CSF to fill.
These findings are important
beyond
just
its
relevance
to Alzheimer’s disease. The
connection between sleep and the
glymphatic system are important as
they help piece together the puzzle
of sleep. Despite the fact that we
spend around 25 years of our life
asleep, it is unclear as to the role
and function that sleep plays37.
Thanks to this glymphatic research,
one goal of sleep appears to be
clearing potentially harmful waste
from the brain and to maintain fluid
balance.
As to how sleep relates to
Alzheimer’s disease, around 65%
of Alzheimer’s patients have a
sleeping disorder, such as insomnia
or sleep apnea 5, 26,. This leads to
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not only a shorter duration of sleep
but also fragmented and poor
quality sleep. Less sleep means
less glymphatic clearance. After
sleep deprivation, amyloid beta
increases in the brain’s CSF and
ISF. The brain does not go into rest
mode so not only is it continuing
to produce amyloid beta, but also
the glymphatic system is unable to
remove the protein from the brain
21, 22, 32
. Furthermore, in Alzheimer’s
brains, sleep deprivation results in
an increase of amyloid plaques17.
Because the brain’s glymphatic
system is unable to function, the
amyloid hangs out in the brain and
is more likely to accumulate.

Sleep More! Doctor’s
Orders!
There are plenty of suggested
daily changes that doctors suggest
to help assuage and slow the
cognitive effects of Alzheimer’s.
Things such as diet, exercise, and
cognitive stimulation have all
been shown to lessen cognitive
deficits1. This current research
about the glymphatic system
shows that improving sleep may be

Micrograph of cerebral amyloid angiopathy
By Nephron from Wikimedia (CC BY-SA)

another way to relieve Alzheimer’s
symptoms. Since impaired sleep
in Alzheimer’s disease can lead to
more amyloid-beta accumulation
and impaired sleep affects the
glymphatic system, improving
sleep
quality
and
quantity
could slow neurodegeneration
by
decreasing
amyloid-beta
accumulation. A recent study
showed that in Alzheimer’s mouse
models, when their symptomatic
disrupted sleep was restored,
amyloid-beta
accumulation
slowed
down
significantly18.
Sleep can be used to harness and
promote the innate function of
the glymphatic system to get rid
of these degenerative proteins.
By sleeping more and sleeping
better, it is possible to protect our
brains from Alzheimer’s disease.
There are currently a lot of sleep
enhancement treatments, such as
melatonin and acoustic stimulation,
which are under investigation as
potential therapies5.
Additionally,
since
the
glymphatic pathway’s efficacy is
impacted in Alzheimer’s, even
before deposition, it is possible
that the early presence of sleep

disruption is the cause of impacted
glymphatic clearance, resulting
in the build-up and deposition of
amyloid-beta. Considering that
altered sleep is one of the earliest
symptoms of Alzheimer’s disease,
researchers are proposing that
paying attention to sleep disruption
appearing later in life may be used
as a tool to diagnose patients at
an earlier stage of the disease 5, 24,
31
. This would then allow patients
to implement treatments, such
as improved sleep therapies,
sooner rather than later which
could significantly slow down the
neurodegenerative effects.
While there is still no absolute
cure for Alzheimer’s disease, this
new field of research about the
glymphatic
system
proposes
an important and innovative
new
treatment
approach.
However, despite the excitement
surrounding
the
glymphatic
system, research can still be done
to better understand exactly
how it works. By increasing our
knowledge about these glymphatic
mechanisms, we will understand
how to optimize its function in
order to slow neurodegeneration
of Alzheimer’s and possibly prevent
it. Additionally, the glymphatic
system has also shown to be a
potential treatment for other
neurodegenerative diseases as well
as ischemic strokes. Furthermore,
a better understanding of the
role sleep plays in the glymphatic
system and Alzheimer’s disease is
especially important as it presents
a possible treatment approach that
is both non-invasive and affordable.
While scientific advancement aids
in the increasing aging population
and prevalence of age-related
diseases, this scientific research is
also how we will be able to conquer
and combat those same diseases.
So the next time you sleep
through your alarm, don’t feel bad
because you’re actually helping
yourself out more than you think.
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